2Huncharek M.Changing risk group for malignant mesothelioma.Cancer,1992,69(2):2 704.
3Antmant KH,Devita VT,Hellman S,et al.Benign and malignant mesothelioma.In:Devita VT,Hellman S,Rosenberg SA,eds,Cancer,principles and practice of oncology.3rd ed.Philadelphia:Lippincott,1989.1 399-1 417.
2Ruffle P, Feld R, Minkin S, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec:a respective study of 332 patients[J]. J Clin Oncol, 1989,7(8):1157.
3Ruseh VW, Piantadose S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma:a lung cancer study group trial[J]. J Thorae Cardiovasc Surg, 1991,102(1 ) : 1.
4From the International Mesothelioma Interest Group. A proposed new international TNM staging system for malignant pleural mesothelioma [J]. Chest, 1995, 108 (4) :122.
5Renshaw AA, Dean RR, Antman KH, et al. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma[J ]. Chest, 1997,111 (1) : 106.
6Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1 : diagnosis [ J ]. Cancer, 1993,72 (2) : 389.
7Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural malignant mesothelioma [J]. Chest, 1995,108(3) :754.
8Carella R. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma, a study with logistic regression analysis[J].Am J Shrg Pathol,2001,25(1) :43.
9Byrne ME, Davidson JA, Musk AW, et al. Cisplatin and gemcitabin treatment for malignant mesothelioma: aphase Ⅱ study [ abstract ] [ M ]. Paper present at the 34 Annul Meeting of the American Society of Clinical Oncology, 1998:16-- 19.
10Linden CJ, Meroke C, Albrechtsson U, et al. Effects of hemithorax irradiation alone or combined with doxorubicin and cyclophosphamide in 47 pleural mesothelioma:a non-randomized phase Ⅱ study [J ]. Eur Respir J,1996,9(12) :2565.
7Huncharek M. Genetic factors in the aetiology of malignant mesothelioma [ J ]. Eur J Cancer, 1995, 83: 2437-2446.
8Spiess PE, Tuziak T, KassoufW, et al. Malignant mesothelioma of the tunica vaginalis [J]. Urology, 2005, 66:397-401.
9Peterson JT, Greenberg SD, Buffler PA. Non - asbestos - related malignant mesothelioma a review [J]. Cancer, 1984, 54:951-958.
10Golash A, Parker J, Ennis O, et al. The interval of development of testieular carcinoma in a patient with previously demonstrated testicular microlithiasis [J]. J Urol, 2000, 163 (1): 239.
